FDA Medical devices recall ·

Caphosol Artificial Saliva (32 doses sachet box) recall

Recall number
Z-2012-2025
Date
(initiated June 11, 2025)
Company / brand
Recordati Rare Diseases Inc.
440 Us Highway 22 Ste 205, Bridgewater, NJ, United States
Category
Medical devices › Class II
Classification
Class II
Status
Ongoing
Units affected
3,754 boxes (120,128 doses)
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Caphosol Artificial Saliva (32 doses sachet box). 64 x 15 mL sachets aqueous solution (32 sachets Solution A Phosphate, 32 sachets Solution B Calcium)

Why was it recalled?

Out of specification stability test result for the Caphosol B solution from process validation lots

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

UDI-DI: 5060146293129. Lot Numbers: 001U002U, 001U002UA. Expiration 2026-10

Distribution

Worldwide - US Nationwide distribution in the states of GA, OH, TN, TX, VA and the countries of Germany, France, Italy, Portugal, Spain, Sweden, United Kingdom.

States: Georgia Ohio Tennessee Texas Virginia

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (medical devices), recall Z-2012-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.